logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Taris Biomedical LLC


USPTO Granted Patents = 61

% Expired Patents = 9.8



Forward Citations = 292

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Heejin Lee (45 out of 55 patents)

silverMedal Karen Danielle Daniel (22 out of 26 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (17 out of 23 patents)

5.  Michael John Cima (10 out of 105 patents)

6.  Matthew Sansone (8 out of 9 patents)

7.  Burleigh M Hutchins, Iii (6 out of 12 patents)

8.  Hong Linh Ho Duc (6 out of 9 patents)

9.  Grace Kim (4 out of 7 patents)

10.  Paul C DiCesare (3 out of 77 patents)

11.  Andrew Barnes (3 out of 7 patents)

12.  Eric Britschock (3 out of 3 patents)

13.  David Sutton (3 out of 3 patents)

14.  Jeffrey P Radziunas (3 out of 60 patents)

15.  Jim Boyko (3 out of 3 patents)


Core Competencies:
Bladder Cancer
Intravesical Device
Drug Delivery
Solid Drug Tablets
Elastic Polymer-Drug Matrix
Multi-Lumen Devices
Trospium Treatment
Implantable Devices
Controlled Drug Release
Urological Devices
Genitourinary Sites
Tumor Metastasis

61 patents:

1. 12582599 - Methods for treatment of bladder cancer with gemcitabine (2026-03-24),
2. 12576253 - Drug delivery device with intravesical tolerability (2026-03-17),
3. 12447241 - Multi-unit drug delivery devices and methods (2025-10-21),
4. 12409304 - Drug delivery devices with drug-permeable component and methods (2025-09-09),
5. 12403086 - Solid drug tablets for implantable drug delivery devices (2025-09-02),
6. 12263244 - Intravesical device for controlled drug delivery (2025-04-01),
7. 12239807 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2025-03-04),
8. 12214148 - Multi-lumen drug delivery devices and methods (2025-02-04),
9. 12133913 - Methods of treating overactive bladder using trospium (2024-11-05),
10. 12090292 - Drug delivery devices and methods for drug delivery (2024-09-17),
11. 12059428 - Methods of treating tumor metastasis (2024-08-13),
12. 12029749 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2024-07-09),
13. 11992583 - Drug delivery devices and methods (2024-05-28),
14. 11904123 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2024-02-20),
15. 11890439 - Drug delivery device with intravesical tolerability (2024-02-06),
Company Overview
Taris Biomedical LLC, based in Lexington, MA, specializes in innovative drug delivery devices aimed at improving treatment outcomes for bladder cancer. The company focuses on developing intravesical devices that utilize solid drug tablets and elastic polymer-drug matrices to enhance the delivery of therapeutic agents directly to the bladder. Their technology encompasses multi-lumen devices and implantable solutions, including those designed for trospium treatment, positioning Taris at the forefront of advancements in localized cancer therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Taris Biomedical LLC USPTO Patent Assignee Logo
61 Patents

#14 in Lexington, MA

#335 in Massachusetts

#5,917 in US

#11,930 in the World

Lexington, MA (US)
Lexington, MA, United States of America

Taris Biomedical LLC

Forward Citations = 292

29 inventors:

goldMedal Heejin Lee (45 out of 55 patents)

silverMedal Karen Danielle Daniel (22 out of 26 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (17 out of 23 patents)

5.  Michael John Cima (10 out of 105 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Taris Biomedical LLC. Retrieved from https://idiyas.com/company/taris-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…